đź“Š Evidence-Based Reference
philips model sl75-10 linear accelerator
Industrial Accelerator
Summary: The Philips Model SL75-10 Linear Accelerator is a medical device used primarily for electron therapy in cancer treatment. It was FDA cleared via the 510(k) pathway in 1987. Key evidence includes studies on dosimetry and fetal dose considerations.
FDA Clearance Information
Pathway
510K
Number
K870525 ↗
Decision Date
April 1, 1987
Product Code
IYE
Device Class
Class 2
Evidence
419 studies
The Philips Model SL75-10 Linear Accelerator was cleared by the FDA through the 510(k) pathway on April 1, 1987. It is manufactured by Industrial Accelerator and classified as a Class 2 device under product code IYE.
What It Is
The Philips Model SL75-10 Linear Accelerator is a device used in radiation therapy, specifically for delivering electron beams to treat cancerous tissues. It is designed to provide precise dosimetry for small and irregular fields, making it suitable for targeted treatments.
Clinical Applications
This device is commonly used in clinical scenarios requiring electron therapy, such as treating superficial tumors located in areas like the lip, nose, and eye. It is particularly useful in shaping fields to conform to irregular treatment areas.
Evidence Summary
The available literature includes two studies published in the early 1980s. These studies focus on dosimetry for shaped fields and fetal dose considerations during electron therapy. The study types include prospective and retrospective analyses.
Reported Outcomes
Published studies report that the Philips SL75-10 provides effective dosimetry for small and irregular fields, which is crucial for treating superficial tumors. The device's ability to shape fields allows for precise targeting of cancerous tissues, potentially improving treatment outcomes.
Safety Profile
Reported complications include considerations of fetal dose during electron therapy, highlighting the need for careful planning in pregnant patients. No other specific adverse events were detailed in the provided studies.
Evidence Limitations
The evidence is limited to studies from the early 1980s, which may not reflect current clinical practices or technological advancements. Further research is needed to evaluate long-term outcomes and safety in diverse patient populations.
Linked Studies (20)
PubMed • 2025
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →
PubMed • 2025
Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →
PubMed • 2025
Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →
PubMed • 2025
Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →
PubMed • 2025
Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →
PubMed • 2025
Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →
PubMed • 2025
pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025
Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →
PubMed • 2025
History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →
PubMed • 2025
A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What are the clinical indications for Philips Model SL75-10 Linear Accelerator?
The device is indicated for electron therapy in treating superficial tumors, particularly in small and irregular fields.
What outcomes have been reported in clinical studies?
Studies report effective dosimetry for small and irregular fields, improving treatment precision for superficial tumors.
What complications have been reported?
Safety data indicate considerations for fetal dose during therapy, with no other specific complications detailed in the studies.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.